DanCann Pharma AS (STU:DAN0) Other Current Liabilities: €0.50 Mil (As of Sep. 2025)


STU:DAN0 DanCann Pharma AS STU:DAN0
27 GF Score
Price €0.00
! 3 Warning Signs
View Full Analysis

What is DanCann Pharma AS Other Current Liabilities?

DanCann Pharma AS STU:DAN0 27 Other Current Liabilities is €0.50 Mil as of Sep. 2025. GuruFocus rates STU:DAN0 with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

DanCann Pharma AS's other current liabilities for the quarter that ended in Sep. 2025 was €0.50 Mil.

DanCann Pharma AS's quarterly other current liabilities increased from Mar. 2025 (€0.03 Mil) to Jun. 2025 (€0.33 Mil) and increased from Jun. 2025 (€0.33 Mil) to Sep. 2025 (€0.50 Mil).

DanCann Pharma AS's annual other current liabilities declined from Dec. 2022 (€0.08 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil).

DanCann Pharma AS Other Current Liabilities Related Terms

DanCann Pharma AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for DanCann Pharma AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DanCann Pharma AS Other Current Liabilities Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial 0.12 1.53 0.08 0.00 0.00

DanCann Pharma AS Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.00 0.03 0.33 0.50
STU:DAN0
27GF Score
DanCann Pharma AS STU:DAN0
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DanCann Pharma AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €0.50 Mil mean?
DanCann Pharma AS (STU:DAN0) has a Other Current Liabilities of €0.50 Mil as of Sep. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DanCann Pharma AS.
Is DanCann Pharma AS's Other Current Liabilities too high?
DanCann Pharma AS's current Other Current Liabilities is €0.50 Mil. Overall, DanCann Pharma AS has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Other Current Liabilities compare to ZTS and UTHR?
DanCann Pharma AS's Other Current Liabilities of €0.50 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DanCann Pharma AS. DanCann Pharma AS's current Other Current Liabilities is €0.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (STU:DAN0) has a current Other Current Liabilities of €0.50 Mil. The current Other Current Liabilities is €0.50 Mil. DanCann Pharma AS's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For DanCann Pharma AS (STU:DAN0), the current Other Current Liabilities is €0.50 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DanCann Pharma AS Business Description

Address Rugvaenget 5, Ansager, DNK, DK-6823
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
27GF Score

Get the complete analysis for STU:DAN0

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price